HAVCR2 and myelodysplastic syndrome: Interestingly, TIM-3 also expresses on leukemic stem and progenitor populations of non-M3 acute myeloid leukemia (AML) and associated with leukemic transformation of preleukemic diseases, such as myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (11).